Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-04-02

Clinical Trial Update: The Effect of Ketamine on Mechanises Underlying Suicidal Ideation and Drug-resistant Major Depression [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating ketamine's effect on suicidal ideation and drug-resistant major depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Suicidal Ideation, Major Depressive Disorder | Phase 3 | Status: UNKNOWN